Toxoplasmosis congénita

Montoya, 2004, Toxoplasmosis, Lancet, 363, 1965, 10.1016/S0140-6736(04)16412-X Dardé, 2004, Genetic analysis of the diversity in Toxoplasma gondii, Ann. Ist. Super. Sanita, 40, 57 Hohlfeld, 1994, Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid, N. Engl. J. Med., 331, 695, 10.1056/NEJM199409153311102 Dunn, 1999, Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling, Lancet, 353, 1829, 10.1016/S0140-6736(98)08220-8 Wilson, 1980, Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection, Pediatrics, 66, 767, 10.1542/peds.66.5.767 Romand, 2001, Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis, Obstet. Gynecol., 97, 296, 10.1016/S0029-7844(00)01118-2 Robert-Gangneux, 1999, Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases, J. Clin. Microbiol., 37, 2893, 10.1128/JCM.37.9.2893-2898.1999 Wallon, 1999, Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy, BMJ, 318, 1511, 10.1136/bmj.318.7197.1511 Hohlfeld, 1989, Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment, J. Pediatr., 115, 765, 10.1016/S0022-3476(89)80660-2 Berrebi, 1994, Termination of pregnancy for maternal toxoplasmosis, Lancet, 344, 36, 10.1016/S0140-6736(94)91054-5 Wallon, 1998, Value of cerebrospinal fluid cytochemical examination for the diagnosis of congenital toxoplasmosis at birth in France, Pediatr. Infect. Dis. J., 17, 705, 10.1097/00006454-199808000-00009 Schoondermark-Van de Ven, 1994, Pharmacokinetics of spiramycin in the Rhesus monkey: transplacental passage and distribution in tissue in the fetus, Antimicrob. Agents Chemother., 38, 1922, 10.1128/AAC.38.9.1922 Peyron, 1996, Long-term follow-up of patients with congenital ocular toxoplasmosis, Lancet, 334, 993 McAuley, 1994, Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago collaborative treatment trial, Clin. Infect. Dis., 18, 38, 10.1093/clinids/18.1.38 Djurkovic-Djakovic, 2000, Serological rebounds after one-year-long treatment for congenital toxoplasmosis, Pediatr. Infect. Dis. J., 19, 81, 10.1097/00006454-200001000-00018 Wallon, 2004, Long-term ocular prognosis in 327 children with congenital toxoplasmosis, Pediatrics, 113, 1567, 10.1542/peds.113.6.1567 Araujo, 1991, Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii, Antimicrob. Agents Chemother., 35, 293, 10.1128/AAC.35.2.293 Baril, 1996, Facteurs de risque d'acquisition de la toxoplasmose chez les femmes enceintes en France (1995), BEH, 51, 227 Binquet, 2003, Prognostic factors for the long-term development of ocular lesions in 327 children with congenital toxoplasmosis, Epidemiol. Infect., 131, 1157, 10.1017/S0950268803001316 Freeman, 2005, Association between congenital toxoplasmosis and preterm birth, low birthweight and small for gestational age birth, BJOG, 112, 31, 10.1111/j.1471-0528.2004.00299.x Gras, 2005, Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres, Acta Paediatr., 94, 1721, 10.1080/08035250500251999 Hohlfeld, 1991, Fetal toxoplasmosis: ultrasonographic signs, Ultrasound Obstet. Gynecol., 1, 241, 10.1046/j.1469-0705.1991.01040241.x Kieffer, 2002, Traitement de la toxoplasmose congénitale non sévère par sulfadiazine et pyriméthamine en continu pendant un an: à propos de 46 cas, Arch. Pediatr., 9, 7, 10.1016/S0929-693X(01)00687-X Koppe, 1986, Results of 20-year follow-up of congenital toxoplasmosis, Lancet, 1, 254, 10.1016/S0140-6736(86)90785-3 Roberts, 2001, Histopathological features of ocular toxoplasmosis in the fetus and infant, Arch. Ophthalmol., 119, 51 Romand, 2004, Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii, Am. J. Obstet. Gynecol., 190, 797, 10.1016/j.ajog.2003.09.039 Wallon, 2001, Serological rebound in congenital toxoplasmosis: long-term follow-up of 133 children, Eur. J. Pediatr., 160, 534, 10.1007/s004310100805